In patients with aAA, activated circulating CD8+ T-cells are a lymphocyte subset that inhibit hematopoiesis19, and 28% of patients with AA have an elevated percentage of activated CD8+ T-cells in their BM20. Here, CD8A is linked to triple-A syndrome.